financetom
Business
financetom
/
Business
/
What's Going On With Lululemon Shares Thursday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Lululemon Shares Thursday?
Aug 15, 2024 8:52 AM

Lululemon Athletica Inc. ( LULU ) shares are moving higher on Thursday, along with other retail stocks, after Walmart ( WMT ) reported strong 2024 fiscal year second quarter earnings before the market opened Thursday.

The Details: Walmart ( WMT ) reported EPS of 67 cents beating analysts estimate of 64 cents and revenue of $169.33 billion beating analysts estimate of $168.56 billion.

What Else: Lululemon is expected to report earnings in two weeks on Aug. 29. Analysts estimate EPS of $2.95 and revenue of $2.41 billion.

Lululemon shares are trading at about $257.07 as of Thursday morning, moving below its 50-day moving average of $283.80. Its 52-week range is between $226.01 and $516.39 and its average session volume is 2.59 million. The stock’s Thursday session volume is 860.77 thousand at the time of publication.

How To Buy Lululemon Stock

By now you're likely curious about how to participate in the market for Lululemon – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the case of Lululemon, which is trading at $253.22 as of publishing time, $100 would buy you 0.39 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource.

Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

See Also: Walmart ( WMT ) Q2 Earnings: E-commerce and Advertising Businesses Fuel Revenue And Profit Beat, Hikes Annual Guidance

LULU Price Action: At the time of writing, Lululemon stock is trading 5.02% higher at $252.67 per data from Benzinga Pro.

Image: Photo via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Northern Trust's profit surges on fee income boost, accounting gain
Northern Trust's profit surges on fee income boost, accounting gain
Jul 17, 2024
(Reuters) - Asset and wealth manager Northern Trust ( NTRS ) posted a more than two-fold jump in second-quarter profit on Wednesday, thanks to higher fee income and an accounting gain of $878.4 million from a stock exchange deal with Visa. Hopes of a soft landing for the U.S. economy and investor frenzy around artificial intelligence have lifted the stock...
Correction: Prologis Q2 Core Funds From Operations, Revenue Falls; Updates 2024 Core FFO Outlook
Correction: Prologis Q2 Core Funds From Operations, Revenue Falls; Updates 2024 Core FFO Outlook
Jul 17, 2024
08:32 AM EDT, 07/17/2024 (MT Newswires) -- Prologis ( PLD ) reported Q2 core funds from operations Wednesday of $1.34 per diluted share, compared with $1.83 a year earlier. Analysts polled by Capital IQ expected $1.07. Total revenue for the quarter ended June 30 was $2.01 billion, down from about $2.45 billion a year earlier. Analysts surveyed by Capital IQ...
Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment
Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment
Jul 17, 2024
08:45 AM EDT, 07/17/2024 (MT Newswires) -- Immutep ( IMMP ) said Wednesday it has received regulatory clearance from the Netherlands' ethics authority to begin human testing of its IMP761 potential autoimmune disease treatment. Immutep ( IMMP ) describes IMP761 as a LAG-3 agonist antibody to potentially treat rheumatoid arthritis, type 1 diabetes, and multiple sclerosis, among other autoimmune diseases....
BioCardia Receives Patent for Morph DNA Transseptal Delivery
BioCardia Receives Patent for Morph DNA Transseptal Delivery
Jul 17, 2024
08:45 AM EDT, 07/17/2024 (MT Newswires) -- BioCardia ( BCDA ) said Wednesday that it was granted a patent for its method for transseptal access to the heart using a steerable catheter based on the company's Morph DNA technology. The patent issued by the US Patent Office protects the company's products through 2035, BioCardia ( BCDA ) said. BioCardia's (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved